Harbor Capital Advisors Inc. Has $1.94 Million Position in OrthoPediatrics Corp. $KIDS

Harbor Capital Advisors Inc. lessened its holdings in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 68.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 104,689 shares of the company’s stock after selling 229,270 shares during the quarter. Harbor Capital Advisors Inc. owned 0.42% of OrthoPediatrics worth $1,940,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in KIDS. Goldman Sachs Group Inc. increased its position in shares of OrthoPediatrics by 112.3% during the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock worth $4,937,000 after acquiring an additional 106,041 shares in the last quarter. Invesco Ltd. boosted its stake in OrthoPediatrics by 12.1% during the 1st quarter. Invesco Ltd. now owns 18,349 shares of the company’s stock valued at $452,000 after purchasing an additional 1,986 shares during the last quarter. Triodos Investment Management BV increased its holdings in OrthoPediatrics by 25.0% during the 2nd quarter. Triodos Investment Management BV now owns 112,500 shares of the company’s stock worth $2,415,000 after purchasing an additional 22,500 shares in the last quarter. American Century Companies Inc. raised its stake in shares of OrthoPediatrics by 16.1% in the first quarter. American Century Companies Inc. now owns 30,658 shares of the company’s stock worth $755,000 after purchasing an additional 4,248 shares during the last quarter. Finally, Birchview Capital LP purchased a new stake in shares of OrthoPediatrics in the first quarter worth approximately $493,000. 69.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. Piper Sandler decreased their price target on OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Lake Street Capital reduced their target price on shares of OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, October 10th. Canaccord Genuity Group initiated coverage on shares of OrthoPediatrics in a report on Wednesday, December 10th. They issued a “buy” rating and a $24.00 target price for the company. Truist Financial set a $18.00 price target on shares of OrthoPediatrics in a report on Friday, October 10th. Finally, Citigroup reiterated an “outperform” rating on shares of OrthoPediatrics in a research note on Friday, October 10th. Eight research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $24.00.

OrthoPediatrics Stock Up 0.8%

OrthoPediatrics stock opened at $17.42 on Friday. The firm has a 50 day moving average price of $17.43 and a 200-day moving average price of $19.35. The company has a quick ratio of 3.52, a current ratio of 7.40 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a twelve month low of $15.28 and a twelve month high of $27.60. The company has a market capitalization of $436.89 million, a P/E ratio of -8.93 and a beta of 1.06.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Monday, January 9th. The company reported ($0.15) EPS for the quarter. OrthoPediatrics had a negative return on equity of 6.86% and a negative net margin of 20.06%.The company had revenue of $25.08 million during the quarter. As a group, equities analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.